Search Within

Hamza Hashmi

Formats
  1. Meeting Abstract (41)
  2. Journal Article (8)
  3. Research Letter (2)
  4. Review (2)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (25)
  2. Department of Medicine (25)
  3. Hematologic Malignancies, Division of (25)
  4. Bone Marrow Transplant (24)
  5. Myeloma (24)
  6. Survivorship Research (24)

More Groups

People
  1. Sridevi Rajeeve (26)
  2. Saad Usmani (25)
  3. Sham Mailankody (24)
  4. Alexander Lesokhin (22)
  5. Carlyn Rose Tan (22)
  6. Heather Landau (22)

More People

Years
  1. 2025 (3)
  2. 2024 (52)
Publications
  1. Blood (27)
  2. Clinical Lymphoma, Myeloma and Leukemia (15)
  3. Blood Cancer Journal (3)
  4. European Journal of Haematology (2)
  5. Blood Advances (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. Elsevier Inc. (16)
  3. John Wiley & Sons (3)
  4. Nature Publishing Group (3)
  5. Biomed Central Ltd (1)
  6. Frontiers Media S.A. (1)

More Publishers

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of older adults and frail patients receiving idecabtagene vicleucel: A CIBMTR study
    Research Letter

    Akhtar, O. S.; Oloyede, T.; Brazauskas, R.; Afrough, A.; Hashmi, H.; Sidana, S.; Ahmed, N.; Bye, M.; Hansen, D.; Ferreri, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
    Research Letter

    Dileo, R.; Mewawalla, P.; Babu, K.; Yin, Y.; Strouse, C.; Chen, E.; Shaikh, H.; Davis, J. A.; Green, K. M.; Alkharabsheh, O.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Addition of elotuzumab to backbone treatment regimens for multiple myeloma: An updated meta-analysis of randomized clinical trials
    Journal Article

    Costa, B. A.; Costa, T. A.; Chagas, G. C. L.; Mouhieddine, T. H.; Richter, J.; Usmani, S. Z.; Mailankody, S.; Rajeeve, S.; Hashmi, H.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • Treatment outcomes of monoclonal gammopathy of renal significance with novel agents
    Meeting Abstract

    Dandwani, M.; Rashid, A.; Moore, D. C.; Balmaceda, J.; Abousaida, B.; Sannareddy, A.; Laverick, P.; Rastogi, P.; Thayyil, A.; Davis, J. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Talquetamab in B cell maturation antigen (BCMA) exposed relapsed-refractory multiple myeloma patients
    Meeting Abstract

    Shaikh, H.; Lochner, J.; Loeffler, B.; Friend, R.; Habib, A.; McKenna, M.; Snyder, J.; Davis, J. A.; Patrus, G.; Dileo, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world safety and efficacy of talquetamab for patients with heavily pretreated relapsed-refractory multiple myeloma
    Meeting Abstract

    Shaikh, H.; Lochner, J.; Loeffler, B.; Friend, R.; Habib, A.; McKenna, M.; Snyder, J.; Davis, J. A.; Patrus, G.; Dileo, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Efficacy of BCMA T-cell engagers (TCE) vs. chimeric antigen receptor T-cell therapy (CAR-T) following BCMA-directed therapies, relapsed/refractory multiple myeloma: The chicken or the egg dilemma
    Meeting Abstract

    Snyder, J.; Ahmed, N.; Mahmoudjafari, Z.; Abdallah, A.; McGuirk, J. P.; Mushtaq, M. U.; Habib, A.; Khan, A. M.; Laharwal, M. M.; Mewawalla, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Belantamab mafodotin, nirogacestat and pomalidomide for patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Hultcrantz, M.; Hassoun, H.; Tan, C. R.; Korde, N.; Lesokhin, A. M.; Hashmi, H.; Maclachlan, K. H.; Rajeeve, S.; Shah, U. A.; Patel, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Rajeeve, S.; Costa, B. A.; Jurgens, E. M.; Nishimura, N.; Farzana, T.; Firestone, R. S.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) for chimeric antigen receptor T-cell therapy (CAR-T) and T-cell engager antibody (TCE) in myeloma and lymphoma
    Meeting Abstract

    Ayoobkhan, F. S.; Qureshi, R.; Rahman, R. L.; Faiz, Z.; Irfan, S.; Iftikhar, A.; Ansari, B.; Mushtaq, M. U.; Abdallah, A. O.; Raza, S.; more...
    Blood (2024)

    Fulltext@MSK | Save